Literature DB >> 22304751

Bicyclic peptide inhibitor reveals large contact interface with a protease target.

Alessandro Angelini1, Laura Cendron, Shiyu Chen, Jeremy Touati, Greg Winter, Giuseppe Zanotti, Christian Heinis.   

Abstract

From a large combinatorial library of chemically constrained bicyclic peptides we isolated a selective and potent (K(i) = 53 nM) inhibitor of human urokinase-type plasminogen activator (uPA) and crystallized the complex. This revealed an extended structure of the peptide with both peptide loops engaging the target to form a large interaction surface of 701 Å(2) with multiple hydrogen bonds and complementary charge interactions, explaining the high affinity and specificity of the inhibitor. The interface resembles that between two proteins and suggests that these constrained peptides have the potential to act as small protein mimics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22304751     DOI: 10.1021/cb200478t

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  37 in total

1.  Peptide bicycles that inhibit the Grb2 SH2 domain.

Authors:  Justin S Quartararo; Pianpian Wu; Joshua A Kritzer
Journal:  Chembiochem       Date:  2012-06-11       Impact factor: 3.164

2.  Highly Constrained Bicyclic Scaffolds for the Discovery of Protease-Stable Peptides via mRNA Display.

Authors:  David E Hacker; Jan Hoinka; Emil S Iqbal; Teresa M Przytycka; Matthew C T Hartman
Journal:  ACS Chem Biol       Date:  2017-02-01       Impact factor: 5.100

3.  Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids.

Authors:  John R Frost; Nicholas T Jacob; Louis J Papa; Andrew E Owens; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2015-05-15       Impact factor: 5.100

4.  Oxadiazole grafts in peptide macrocycles.

Authors:  John R Frost; Conor C G Scully; Andrei K Yudin
Journal:  Nat Chem       Date:  2016-10-24       Impact factor: 24.427

5.  Exhaustive Conformational Sampling of Complex Fused Ring Macrocycles Using Inverse Kinematics.

Authors:  Evangelos A Coutsias; Katrina W Lexa; Michael J Wester; Sara N Pollock; Matthew P Jacobson
Journal:  J Chem Theory Comput       Date:  2016-08-04       Impact factor: 6.006

6.  Development of Potent and Selective S. aureus Sortase A Inhibitors Based on Peptide Macrocycles.

Authors:  Inmaculada Rentero Rebollo; Shawna McCallin; Davide Bertoldo; José Manuel Entenza; Philippe Moreillon; Christian Heinis
Journal:  ACS Med Chem Lett       Date:  2016-04-14       Impact factor: 4.345

7.  De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures.

Authors:  Bobo Dang; Haifan Wu; Vikram Khipple Mulligan; Marco Mravic; Yibing Wu; Thomas Lemmin; Alexander Ford; Daniel-Adriano Silva; David Baker; William F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

8.  Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1.

Authors:  Walaa Bedewy; Hui Liao; Nageh A Abou-Taleb; Sherif F Hammad; Tamer Nasr; Dehua Pei
Journal:  Org Biomol Chem       Date:  2017-05-31       Impact factor: 3.876

9.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

10.  Design, construction, and characterization of a second-generation DARP in library with reduced hydrophobicity.

Authors:  Markus A Seeger; Reto Zbinden; Andreas Flütsch; Petrus G M Gutte; Sibylle Engeler; Heidi Roschitzki-Voser; Markus G Grütter
Journal:  Protein Sci       Date:  2013-08-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.